# Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer

> **NCT04119622** · PHASE2 · UNKNOWN · sponsor: **Aiping Zhou** · enrollment: 30 (estimated)

## Conditions studied

- Gastric Cancer Stage II
- Gastric Cancer Stage III

## Interventions

- **DRUG:** Toripalimab
- **DRUG:** oxaliplatin
- **DRUG:** capecitabine

## Key facts

- **NCT ID:** NCT04119622
- **Lead sponsor:** Aiping Zhou
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-08
- **Primary completion:** 2022-09-30
- **Final completion:** 2024-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119622

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119622, "Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04119622. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*